Cargando…
A pilot study of rizatriptan and visually-induced motion sickness in migraineurs
Background: Limited evidence suggests that rizatriptan given before vestibular stimulation reduces motion sickness in persons with migraine-related dizziness. The present study was designed to test whether rizatriptan is also effective in protecting against visually-induced motion sickness and to te...
Autores principales: | Furman, Joseph M., Marcus, Dawn A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726576/ https://www.ncbi.nlm.nih.gov/pubmed/19680473 |
Ejemplares similares
-
Rizatriptan reduces vestibular-induced motion sickness in migraineurs
por: Furman, Joseph M., et al.
Publicado: (2010) -
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial
por: Barbanti, Piero, et al.
Publicado: (2012) -
Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine
por: Krymchantowski, Abouch Valenty, et al.
Publicado: (2004) -
Rizatriptan in the treatment of migraine
por: Láinez, Miguel JA
Publicado: (2006) -
Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets
por: Keny, R. V., et al.
Publicado: (2010)